Structure

Physi-Chem Properties

Molecular Weight:  436.19
Volume:  453.039
LogP:  5.969
LogD:  3.463
LogS:  -3.623
# Rotatable Bonds:  4
TPSA:  100.13
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.368
Synthetic Accessibility Score:  3.523
Fsp3:  0.346
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.768
MDCK Permeability:  1.4376710169017315e-05
Pgp-inhibitor:  0.502
Pgp-substrate:  0.869
Human Intestinal Absorption (HIA):  0.028
20% Bioavailability (F20%):  0.761
30% Bioavailability (F30%):  0.793

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.002
Plasma Protein Binding (PPB):  95.33914184570312%
Volume Distribution (VD):  0.625
Pgp-substrate:  4.8516716957092285%

ADMET: Metabolism

CYP1A2-inhibitor:  0.632
CYP1A2-substrate:  0.893
CYP2C19-inhibitor:  0.635
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.779
CYP2C9-substrate:  0.907
CYP2D6-inhibitor:  0.469
CYP2D6-substrate:  0.892
CYP3A4-inhibitor:  0.233
CYP3A4-substrate:  0.177

ADMET: Excretion

Clearance (CL):  5.283
Half-life (T1/2):  0.222

ADMET: Toxicity

hERG Blockers:  0.017
Human Hepatotoxicity (H-HT):  0.09
Drug-inuced Liver Injury (DILI):  0.546
AMES Toxicity:  0.396
Rat Oral Acute Toxicity:  0.62
Maximum Recommended Daily Dose:  0.94
Skin Sensitization:  0.923
Carcinogencity:  0.104
Eye Corrosion:  0.003
Eye Irritation:  0.899
Respiratory Toxicity:  0.94

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC297212

Natural Product ID:  NPC297212
Common Name*:   Ugonin K
IUPAC Name:   2-(3,4-dihydroxyphenyl)-6-[[(1S)-2,2-dimethyl-6-methylidenecyclohexyl]methyl]-5-hydroxy-7-methoxychromen-4-one
Synonyms:   Ugonin K
Standard InCHIKey:  ROCKAKPPZWGROR-QGZVFWFLSA-N
Standard InCHI:  InChI=1S/C26H28O6/c1-14-6-5-9-26(2,3)17(14)11-16-22(31-4)13-23-24(25(16)30)20(29)12-21(32-23)15-7-8-18(27)19(28)10-15/h7-8,10,12-13,17,27-28,30H,1,5-6,9,11H2,2-4H3/t17-/m1/s1
SMILES:  C=C1CCCC(C)(C)[C@@H]1Cc1c(cc2c(c(=O)cc(c3ccc(c(c3)O)O)o2)c1O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL563689
PubChem CID:   12114698
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001615] Flavones
          • [CHEMONTID:0003503] 6-prenylated flavones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota rhizomes n.a. n.a. PMID[19583252]
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota Rhizomes n.a. n.a. PMID[28169537]
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 > 10000.0 nM PMID[514265]
NPT83 Cell Line MCF7 Homo sapiens IC50 > 10000.0 nM PMID[514265]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[514265]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 2000.0 nM PMID[514265]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC297212 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9934 High Similarity NPC46736
0.9868 High Similarity NPC476280
0.9805 High Similarity NPC476295
0.9805 High Similarity NPC12461
0.9803 High Similarity NPC197856
0.974 High Similarity NPC206605
0.9542 High Similarity NPC3980
0.9484 High Similarity NPC476283
0.947 High Similarity NPC88804
0.947 High Similarity NPC3825
0.9423 High Similarity NPC32694
0.9423 High Similarity NPC472275
0.9412 High Similarity NPC170492
0.9371 High Similarity NPC476306
0.9363 High Similarity NPC474150
0.9363 High Similarity NPC474162
0.9363 High Similarity NPC78332
0.9359 High Similarity NPC235018
0.9359 High Similarity NPC45146
0.9359 High Similarity NPC28241
0.9355 High Similarity NPC273843
0.9351 High Similarity NPC133392
0.9346 High Similarity NPC157784
0.9346 High Similarity NPC471982
0.9346 High Similarity NPC63187
0.9346 High Similarity NPC37684
0.9304 High Similarity NPC220313
0.9304 High Similarity NPC186686
0.9299 High Similarity NPC187354
0.9299 High Similarity NPC234644
0.9299 High Similarity NPC278427
0.9299 High Similarity NPC57715
0.9299 High Similarity NPC472906
0.9295 High Similarity NPC172770
0.9295 High Similarity NPC235448
0.9295 High Similarity NPC210459
0.9295 High Similarity NPC185258
0.929 High Similarity NPC471985
0.929 High Similarity NPC170026
0.929 High Similarity NPC276444
0.929 High Similarity NPC475799
0.929 High Similarity NPC282307
0.929 High Similarity NPC13779
0.9286 High Similarity NPC213896
0.9286 High Similarity NPC192083
0.9281 High Similarity NPC154345
0.9281 High Similarity NPC59162
0.9281 High Similarity NPC205046
0.9281 High Similarity NPC304295
0.9272 High Similarity NPC108406
0.9245 High Similarity NPC239752
0.9245 High Similarity NPC156432
0.9245 High Similarity NPC275780
0.9245 High Similarity NPC472450
0.9241 High Similarity NPC329760
0.9236 High Similarity NPC119209
0.9236 High Similarity NPC471973
0.9236 High Similarity NPC80375
0.9236 High Similarity NPC36217
0.9236 High Similarity NPC192686
0.9236 High Similarity NPC118256
0.9236 High Similarity NPC321399
0.9236 High Similarity NPC188433
0.9231 High Similarity NPC219867
0.9231 High Similarity NPC161960
0.9231 High Similarity NPC218871
0.9231 High Similarity NPC471209
0.9231 High Similarity NPC237418
0.9231 High Similarity NPC187745
0.9231 High Similarity NPC476630
0.9231 High Similarity NPC304008
0.9231 High Similarity NPC180011
0.9231 High Similarity NPC79053
0.9226 High Similarity NPC321779
0.9226 High Similarity NPC67396
0.9226 High Similarity NPC56786
0.9226 High Similarity NPC80534
0.9226 High Similarity NPC234255
0.9221 High Similarity NPC249570
0.9221 High Similarity NPC106976
0.9193 High Similarity NPC165456
0.9193 High Similarity NPC300307
0.9193 High Similarity NPC288813
0.9193 High Similarity NPC188079
0.9187 High Similarity NPC43319
0.9187 High Similarity NPC171985
0.9187 High Similarity NPC320741
0.9187 High Similarity NPC39091
0.9182 High Similarity NPC207690
0.9182 High Similarity NPC23298
0.9182 High Similarity NPC306321
0.9182 High Similarity NPC303460
0.9182 High Similarity NPC189473
0.9177 High Similarity NPC142252
0.9177 High Similarity NPC26326
0.9177 High Similarity NPC474038
0.9177 High Similarity NPC198829
0.9172 High Similarity NPC53545
0.9172 High Similarity NPC204879
0.9172 High Similarity NPC85121
0.9172 High Similarity NPC74178
0.9172 High Similarity NPC469658
0.9172 High Similarity NPC184755
0.9172 High Similarity NPC117418
0.9167 High Similarity NPC278778
0.9167 High Similarity NPC24640
0.9167 High Similarity NPC291878
0.9167 High Similarity NPC142339
0.9167 High Similarity NPC115853
0.9167 High Similarity NPC195796
0.9167 High Similarity NPC472455
0.9167 High Similarity NPC35038
0.9161 High Similarity NPC74924
0.9161 High Similarity NPC298692
0.9161 High Similarity NPC476631
0.9156 High Similarity NPC305965
0.915 High Similarity NPC52005
0.915 High Similarity NPC87125
0.915 High Similarity NPC171916
0.915 High Similarity NPC137062
0.915 High Similarity NPC177298
0.915 High Similarity NPC270465
0.915 High Similarity NPC223579
0.915 High Similarity NPC38545
0.915 High Similarity NPC48479
0.915 High Similarity NPC287101
0.915 High Similarity NPC183950
0.913 High Similarity NPC218226
0.9125 High Similarity NPC303174
0.9125 High Similarity NPC473286
0.9125 High Similarity NPC293319
0.9125 High Similarity NPC472277
0.9119 High Similarity NPC83922
0.9119 High Similarity NPC470694
0.9119 High Similarity NPC194427
0.9119 High Similarity NPC472448
0.9119 High Similarity NPC476247
0.9119 High Similarity NPC229632
0.9119 High Similarity NPC201800
0.9114 High Similarity NPC228785
0.9114 High Similarity NPC475784
0.9114 High Similarity NPC474960
0.9114 High Similarity NPC328102
0.9114 High Similarity NPC14353
0.9114 High Similarity NPC204290
0.9114 High Similarity NPC476980
0.9114 High Similarity NPC56085
0.9108 High Similarity NPC78225
0.9108 High Similarity NPC218313
0.9108 High Similarity NPC136674
0.9108 High Similarity NPC299520
0.9108 High Similarity NPC284820
0.9108 High Similarity NPC473272
0.9108 High Similarity NPC236796
0.9108 High Similarity NPC474055
0.9108 High Similarity NPC291508
0.9108 High Similarity NPC129684
0.9108 High Similarity NPC472598
0.9108 High Similarity NPC27337
0.9108 High Similarity NPC474681
0.9108 High Similarity NPC52889
0.9103 High Similarity NPC168247
0.9103 High Similarity NPC117992
0.9103 High Similarity NPC470327
0.9103 High Similarity NPC113906
0.9103 High Similarity NPC230149
0.9103 High Similarity NPC45849
0.9103 High Similarity NPC200761
0.9103 High Similarity NPC472280
0.9103 High Similarity NPC152951
0.9103 High Similarity NPC57674
0.9103 High Similarity NPC477503
0.9097 High Similarity NPC237994
0.9097 High Similarity NPC60972
0.9097 High Similarity NPC39732
0.9097 High Similarity NPC260979
0.9097 High Similarity NPC472912
0.9097 High Similarity NPC324233
0.9097 High Similarity NPC323626
0.9091 High Similarity NPC184136
0.9091 High Similarity NPC149127
0.9091 High Similarity NPC286342
0.9091 High Similarity NPC188871
0.9091 High Similarity NPC85131
0.9085 High Similarity NPC119059
0.9085 High Similarity NPC166036
0.9085 High Similarity NPC120464
0.9085 High Similarity NPC238279
0.9085 High Similarity NPC3036
0.9085 High Similarity NPC203077
0.9085 High Similarity NPC195202
0.908 High Similarity NPC4200
0.9074 High Similarity NPC476637
0.9074 High Similarity NPC107627
0.9073 High Similarity NPC279121
0.9073 High Similarity NPC11700
0.9068 High Similarity NPC224851
0.9068 High Similarity NPC472449
0.9068 High Similarity NPC37870
0.9062 High Similarity NPC270837

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC297212 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9286 High Similarity NPD2393 Clinical (unspecified phase)
0.9073 High Similarity NPD1511 Approved
0.9038 High Similarity NPD2801 Approved
0.8974 High Similarity NPD1934 Approved
0.8954 High Similarity NPD1512 Approved
0.8889 High Similarity NPD4378 Clinical (unspecified phase)
0.8773 High Similarity NPD6168 Clinical (unspecified phase)
0.8773 High Similarity NPD6166 Phase 2
0.8773 High Similarity NPD6167 Clinical (unspecified phase)
0.8645 High Similarity NPD7410 Clinical (unspecified phase)
0.8625 High Similarity NPD8443 Clinical (unspecified phase)
0.8608 High Similarity NPD4380 Phase 2
0.8606 High Similarity NPD7473 Discontinued
0.8571 High Similarity NPD3882 Suspended
0.8537 High Similarity NPD6232 Discontinued
0.8528 High Similarity NPD5494 Approved
0.8509 High Similarity NPD3817 Phase 2
0.8503 High Similarity NPD7054 Approved
0.8476 Intermediate Similarity NPD6959 Discontinued
0.8457 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8452 Intermediate Similarity NPD7074 Phase 3
0.8452 Intermediate Similarity NPD7472 Approved
0.8447 Intermediate Similarity NPD7819 Suspended
0.8443 Intermediate Similarity NPD3818 Discontinued
0.8402 Intermediate Similarity NPD6797 Phase 2
0.8353 Intermediate Similarity NPD7251 Discontinued
0.8323 Intermediate Similarity NPD7411 Suspended
0.8312 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8312 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8301 Intermediate Similarity NPD1510 Phase 2
0.8293 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD7075 Discontinued
0.8284 Intermediate Similarity NPD5844 Phase 1
0.8258 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8258 Intermediate Similarity NPD1549 Phase 2
0.8247 Intermediate Similarity NPD2796 Approved
0.8221 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8205 Intermediate Similarity NPD2800 Approved
0.8198 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8198 Intermediate Similarity NPD7808 Phase 3
0.8176 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD6801 Discontinued
0.8158 Intermediate Similarity NPD1240 Approved
0.8153 Intermediate Similarity NPD3750 Approved
0.8148 Intermediate Similarity NPD6599 Discontinued
0.8121 Intermediate Similarity NPD7768 Phase 2
0.811 Intermediate Similarity NPD1465 Phase 2
0.8107 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8052 Intermediate Similarity NPD1607 Approved
0.8039 Intermediate Similarity NPD943 Approved
0.8013 Intermediate Similarity NPD6099 Approved
0.8013 Intermediate Similarity NPD6100 Approved
0.8 Intermediate Similarity NPD6799 Approved
0.7977 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD3749 Approved
0.795 Intermediate Similarity NPD2532 Approved
0.795 Intermediate Similarity NPD2534 Approved
0.795 Intermediate Similarity NPD2533 Approved
0.7935 Intermediate Similarity NPD6651 Approved
0.7898 Intermediate Similarity NPD2935 Discontinued
0.7888 Intermediate Similarity NPD7390 Discontinued
0.7866 Intermediate Similarity NPD3226 Approved
0.7862 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD5402 Approved
0.7834 Intermediate Similarity NPD3748 Approved
0.7834 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD6559 Discontinued
0.7824 Intermediate Similarity NPD1247 Approved
0.7811 Intermediate Similarity NPD919 Approved
0.7792 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD5403 Approved
0.7733 Intermediate Similarity NPD3926 Phase 2
0.773 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD2799 Discontinued
0.7722 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7199 Phase 2
0.7712 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD6234 Discontinued
0.7702 Intermediate Similarity NPD4628 Phase 3
0.7702 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD1613 Approved
0.7692 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7662 Intermediate Similarity NPD4908 Phase 1
0.7643 Intermediate Similarity NPD230 Phase 1
0.764 Intermediate Similarity NPD1243 Approved
0.7636 Intermediate Similarity NPD920 Approved
0.7636 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD2346 Discontinued
0.7622 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD5401 Approved
0.7564 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD2313 Discontinued
0.7562 Intermediate Similarity NPD1551 Phase 2
0.7556 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7554 Intermediate Similarity NPD4360 Phase 2
0.7554 Intermediate Similarity NPD4363 Phase 3
0.7545 Intermediate Similarity NPD7458 Discontinued
0.7542 Intermediate Similarity NPD8312 Approved
0.7542 Intermediate Similarity NPD8313 Approved
0.7541 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2344 Approved
0.7515 Intermediate Similarity NPD37 Approved
0.7515 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3027 Phase 3
0.75 Intermediate Similarity NPD7228 Approved
0.75 Intermediate Similarity NPD3751 Discontinued
0.75 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7003 Approved
0.7485 Intermediate Similarity NPD4965 Approved
0.7485 Intermediate Similarity NPD4966 Approved
0.7485 Intermediate Similarity NPD8166 Discontinued
0.7485 Intermediate Similarity NPD4967 Phase 2
0.7472 Intermediate Similarity NPD5953 Discontinued
0.7471 Intermediate Similarity NPD7229 Phase 3
0.7471 Intermediate Similarity NPD3787 Discontinued
0.7458 Intermediate Similarity NPD7286 Phase 2
0.7455 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD3268 Approved
0.744 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD447 Suspended
0.7419 Intermediate Similarity NPD2798 Approved
0.7418 Intermediate Similarity NPD8434 Phase 2
0.7389 Intermediate Similarity NPD4625 Phase 3
0.738 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD5710 Approved
0.7371 Intermediate Similarity NPD5711 Approved
0.7365 Intermediate Similarity NPD6273 Approved
0.7355 Intermediate Similarity NPD2797 Approved
0.7346 Intermediate Similarity NPD5404 Approved
0.7346 Intermediate Similarity NPD5405 Approved
0.7346 Intermediate Similarity NPD5406 Approved
0.7346 Intermediate Similarity NPD5408 Approved
0.7333 Intermediate Similarity NPD2309 Approved
0.7326 Intermediate Similarity NPD4361 Phase 2
0.7326 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7322 Intermediate Similarity NPD8150 Discontinued
0.732 Intermediate Similarity NPD1610 Phase 2
0.732 Intermediate Similarity NPD1201 Approved
0.7314 Intermediate Similarity NPD8127 Discontinued
0.7273 Intermediate Similarity NPD1608 Approved
0.7267 Intermediate Similarity NPD5761 Phase 2
0.7267 Intermediate Similarity NPD5760 Phase 2
0.7263 Intermediate Similarity NPD6781 Approved
0.7263 Intermediate Similarity NPD6779 Approved
0.7263 Intermediate Similarity NPD6777 Approved
0.7263 Intermediate Similarity NPD6776 Approved
0.7263 Intermediate Similarity NPD6778 Approved
0.7263 Intermediate Similarity NPD6780 Approved
0.7263 Intermediate Similarity NPD6782 Approved
0.725 Intermediate Similarity NPD4060 Phase 1
0.7244 Intermediate Similarity NPD1470 Approved
0.7244 Intermediate Similarity NPD1203 Approved
0.7238 Intermediate Similarity NPD7685 Pre-registration
0.7233 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD8151 Discontinued
0.7229 Intermediate Similarity NPD6190 Approved
0.7226 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD4288 Approved
0.7205 Intermediate Similarity NPD5124 Phase 1
0.7205 Intermediate Similarity NPD1933 Approved
0.7205 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD7033 Discontinued
0.7176 Intermediate Similarity NPD1653 Approved
0.7171 Intermediate Similarity NPD1548 Phase 1
0.7161 Intermediate Similarity NPD3972 Approved
0.7152 Intermediate Similarity NPD9494 Approved
0.7151 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7435 Discontinued
0.7134 Intermediate Similarity NPD3266 Approved
0.7134 Intermediate Similarity NPD3267 Approved
0.7128 Intermediate Similarity NPD7584 Approved
0.7115 Intermediate Similarity NPD4749 Approved
0.7111 Intermediate Similarity NPD7177 Discontinued
0.7107 Intermediate Similarity NPD6832 Phase 2
0.7099 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD422 Phase 1
0.7097 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD2403 Approved
0.7083 Intermediate Similarity NPD3300 Phase 2
0.7078 Intermediate Similarity NPD17 Approved
0.7073 Intermediate Similarity NPD4308 Phase 3
0.7071 Intermediate Similarity NPD7783 Phase 2
0.7071 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD3225 Approved
0.7069 Intermediate Similarity NPD8455 Phase 2
0.7063 Intermediate Similarity NPD7095 Approved
0.7062 Intermediate Similarity NPD7697 Approved
0.7062 Intermediate Similarity NPD7696 Phase 3
0.7062 Intermediate Similarity NPD7698 Approved
0.7059 Intermediate Similarity NPD4287 Approved
0.7051 Intermediate Similarity NPD9717 Approved
0.7051 Intermediate Similarity NPD9269 Phase 2
0.7049 Intermediate Similarity NPD7240 Approved
0.7047 Intermediate Similarity NPD2493 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data